Cargando…
Infant formula containing bovine milk-derived oligosaccharides supports age-appropriate growth and improves stooling pattern
BACKGROUND: Adding bovine milk-derived oligosaccharides (MOS) enhances the oligosaccharide profile of infant formula. This study aimed to evaluate the safety and efficacy of a MOS-supplemented infant formula. METHODS: In this double-blind randomized controlled trial, healthy infants 21–26 days old w...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197766/ https://www.ncbi.nlm.nih.gov/pubmed/33958719 http://dx.doi.org/10.1038/s41390-021-01541-3 |
_version_ | 1784727486694686720 |
---|---|
author | Estorninos, E. Lawenko, R. B. Palestroque, E. Lebumfacil, J. Marko, M. Cercamondi, C. I. |
author_facet | Estorninos, E. Lawenko, R. B. Palestroque, E. Lebumfacil, J. Marko, M. Cercamondi, C. I. |
author_sort | Estorninos, E. |
collection | PubMed |
description | BACKGROUND: Adding bovine milk-derived oligosaccharides (MOS) enhances the oligosaccharide profile of infant formula. This study aimed to evaluate the safety and efficacy of a MOS-supplemented infant formula. METHODS: In this double-blind randomized controlled trial, healthy infants 21–26 days old were either assigned to bovine milk-based, alpha-lactalbumin, and sn-2 palmitate enriched infant formula (control, n = 115) or the same formula with 7.2 g MOS/L (test, n = 115) until aged 6 months. Co-primary endpoints were weight gain through 4 months and stool consistency (validated scale: 1 = watery to 5 = hard). Secondary endpoints included parent-reported GI tolerance, health-related quality of life (HRQoL), and adverse events (AEs). RESULTS: Weight gain was similar (p = 0.695); the difference between test and control (mean; 95% CI: 0.29; −1.15, 1.73 g/day) was above the non-inferiority margin (−3 g/day). Test had softer stools than control (mean difference in stool consistency score: −0.31; 95% CI: −0.42, −0.21; P < 0.0001); fewer parental reports of harder stools (OR = 0.32, 95% CI: 0.20, 0.49; P < 0.0001) and less difficulties in passing stool (OR = 0.25, 95% CI: 0.09, 0.65; P = 0.005). Parent-reported GI tolerance and HRQoL were similar between groups as were the overall low AEs. CONCLUSIONS: MOS-supplemented infant formula is safe and well-tolerated while supporting normal infant growth and promotes softer stooling pattern without increasing parent-reported and physician-confirmed adverse health concerns. IMPACT: This is the first study investigating the addition of bovine milk-derived oligosaccharides to an infant formula enriched with alpha-lactalbumin and elevated levels of sn-2 palmitate, providing safety and efficacy data for such a formula. Term infant formula supplemented with 7.2 g bovine milk-derived oligosaccharides per liter supported normal infant growth, was well-tolerated and safe. Addition of bovine milk-derived oligosaccharides to term infant formula promoted softer stooling pattern and reduced difficulties in passing stool. The study shows that bovine milk-derived oligosaccharide supplemented infant formula is a safe and effective option for healthy term infants who are formula-fed. |
format | Online Article Text |
id | pubmed-9197766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-91977662022-06-16 Infant formula containing bovine milk-derived oligosaccharides supports age-appropriate growth and improves stooling pattern Estorninos, E. Lawenko, R. B. Palestroque, E. Lebumfacil, J. Marko, M. Cercamondi, C. I. Pediatr Res Clinical Research Article BACKGROUND: Adding bovine milk-derived oligosaccharides (MOS) enhances the oligosaccharide profile of infant formula. This study aimed to evaluate the safety and efficacy of a MOS-supplemented infant formula. METHODS: In this double-blind randomized controlled trial, healthy infants 21–26 days old were either assigned to bovine milk-based, alpha-lactalbumin, and sn-2 palmitate enriched infant formula (control, n = 115) or the same formula with 7.2 g MOS/L (test, n = 115) until aged 6 months. Co-primary endpoints were weight gain through 4 months and stool consistency (validated scale: 1 = watery to 5 = hard). Secondary endpoints included parent-reported GI tolerance, health-related quality of life (HRQoL), and adverse events (AEs). RESULTS: Weight gain was similar (p = 0.695); the difference between test and control (mean; 95% CI: 0.29; −1.15, 1.73 g/day) was above the non-inferiority margin (−3 g/day). Test had softer stools than control (mean difference in stool consistency score: −0.31; 95% CI: −0.42, −0.21; P < 0.0001); fewer parental reports of harder stools (OR = 0.32, 95% CI: 0.20, 0.49; P < 0.0001) and less difficulties in passing stool (OR = 0.25, 95% CI: 0.09, 0.65; P = 0.005). Parent-reported GI tolerance and HRQoL were similar between groups as were the overall low AEs. CONCLUSIONS: MOS-supplemented infant formula is safe and well-tolerated while supporting normal infant growth and promotes softer stooling pattern without increasing parent-reported and physician-confirmed adverse health concerns. IMPACT: This is the first study investigating the addition of bovine milk-derived oligosaccharides to an infant formula enriched with alpha-lactalbumin and elevated levels of sn-2 palmitate, providing safety and efficacy data for such a formula. Term infant formula supplemented with 7.2 g bovine milk-derived oligosaccharides per liter supported normal infant growth, was well-tolerated and safe. Addition of bovine milk-derived oligosaccharides to term infant formula promoted softer stooling pattern and reduced difficulties in passing stool. The study shows that bovine milk-derived oligosaccharide supplemented infant formula is a safe and effective option for healthy term infants who are formula-fed. Nature Publishing Group US 2021-05-06 2022 /pmc/articles/PMC9197766/ /pubmed/33958719 http://dx.doi.org/10.1038/s41390-021-01541-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Clinical Research Article Estorninos, E. Lawenko, R. B. Palestroque, E. Lebumfacil, J. Marko, M. Cercamondi, C. I. Infant formula containing bovine milk-derived oligosaccharides supports age-appropriate growth and improves stooling pattern |
title | Infant formula containing bovine milk-derived oligosaccharides supports age-appropriate growth and improves stooling pattern |
title_full | Infant formula containing bovine milk-derived oligosaccharides supports age-appropriate growth and improves stooling pattern |
title_fullStr | Infant formula containing bovine milk-derived oligosaccharides supports age-appropriate growth and improves stooling pattern |
title_full_unstemmed | Infant formula containing bovine milk-derived oligosaccharides supports age-appropriate growth and improves stooling pattern |
title_short | Infant formula containing bovine milk-derived oligosaccharides supports age-appropriate growth and improves stooling pattern |
title_sort | infant formula containing bovine milk-derived oligosaccharides supports age-appropriate growth and improves stooling pattern |
topic | Clinical Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197766/ https://www.ncbi.nlm.nih.gov/pubmed/33958719 http://dx.doi.org/10.1038/s41390-021-01541-3 |
work_keys_str_mv | AT estorninose infantformulacontainingbovinemilkderivedoligosaccharidessupportsageappropriategrowthandimprovesstoolingpattern AT lawenkorb infantformulacontainingbovinemilkderivedoligosaccharidessupportsageappropriategrowthandimprovesstoolingpattern AT palestroquee infantformulacontainingbovinemilkderivedoligosaccharidessupportsageappropriategrowthandimprovesstoolingpattern AT lebumfacilj infantformulacontainingbovinemilkderivedoligosaccharidessupportsageappropriategrowthandimprovesstoolingpattern AT markom infantformulacontainingbovinemilkderivedoligosaccharidessupportsageappropriategrowthandimprovesstoolingpattern AT cercamondici infantformulacontainingbovinemilkderivedoligosaccharidessupportsageappropriategrowthandimprovesstoolingpattern |